Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

Clinical trial NCT05784688 · RECRUITING

Trial details

NCT number: NCT05784688
Sponsor: TiumBio Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Biliary Tract Cancer Head and Neck Squamous Cell Carcinoma Colorectal Cancer

Start date: 2023-03-10
Primary completion: 2026-12-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.